PT Tempo Scan Pacific Tbk (TSPC.JK)

IDR 2430.0

(-1.62%)

EBITDA Summary of PT Tempo Scan Pacific Tbk

  • PT Tempo Scan Pacific Tbk's latest annual EBITDA in 2023 was 1997.6 Billion IDR , up 64.29% from previous year.
  • PT Tempo Scan Pacific Tbk's latest quarterly EBITDA in 2024 Q3 was 486.69 Billion IDR , down -30.22% from previous quarter.
  • PT Tempo Scan Pacific Tbk reported an annual EBITDA of 1670.68 Billion IDR in 2022, down -29.91% from previous year.
  • PT Tempo Scan Pacific Tbk reported an annual EBITDA of 1434.08 Billion IDR in 2021, up 3.09% from previous year.
  • PT Tempo Scan Pacific Tbk reported a quarterly EBITDA of 486.69 Billion IDR for 2024 Q3, down -30.22% from previous quarter.
  • PT Tempo Scan Pacific Tbk reported a quarterly EBITDA of 582 Billion IDR for 2024 Q2, up 4.49% from previous quarter.

Annual EBITDA Chart of PT Tempo Scan Pacific Tbk (2023 - 2005)

Historical Annual EBITDA of PT Tempo Scan Pacific Tbk (2023 - 2005)

Year EBITDA EBITDA Growth
2023 1997.6 Billion IDR 64.29%
2022 1670.68 Billion IDR -29.91%
2021 1434.08 Billion IDR 3.09%
2020 1393.48 Billion IDR 31.32%
2019 1082.39 Billion IDR 11.53%
2018 955.56 Billion IDR 8.88%
2017 950.75 Billion IDR -5.49%
2016 907.08 Billion IDR 1.11%
2015 829.69 Billion IDR 3.22%
2014 836.95 Billion IDR -7.72%
2013 911.76 Billion IDR 5.93%
2012 860.69 Billion IDR 29.85%
2011 662.81 Billion IDR 10.96%
2010 597.34 Billion IDR 35.96%
2009 445.55 Billion IDR 21.29%
2008 362.24 Billion IDR 13.94%
2007 320.56 Billion IDR 1.83%
2006 314.04 Billion IDR -10.63%
2005 353.48 Billion IDR 0.0%

Peer EBITDA Comparison of PT Tempo Scan Pacific Tbk

Name EBITDA EBITDA Difference
PT Darya-Varia Laboratoria Tbk 255.91 Billion IDR -680.574%
PT Merck Tbk 239.49 Billion IDR -734.099%
PT Phapros, Tbk 120.77 Billion IDR -1554.0%
PT Pyridam Farma Tbk 60.69 Billion IDR -3191.091%
PT Industri Jamu dan Farmasi Sido Muncul Tbk 1323.93 Billion IDR -50.884%